Development of Sustained Release Floating Drug Delivery System for Norfloxacin: In Vitro and In Vivo Evaluation

References

1. 1.↵
   1. Singh B. N.,
   2. Kim K. H.

   Floating drug delivery systems: an approach to oral controlled drug delivery via gastric retention. J. Controlled Release 2000, 63 (3), 235–259.

   OpenUrlPubMed
2. 2.↵
   1. Streubel A.,
   2. Siepmann J.,
   3. Bodmeier R.

   Floating matrix tablets based on low-density foam powder: effects of formulation and processing parameters on drug release. Eur. J. Pharm. Sci. 2003, 18 (1), 37–45.

   OpenUrlPubMed
3. 3.↵
   1. Park K.,
   2. Robinson J. R.

   Bioadhesive polymers as platforms for oral-controlled drug delivery: method to study bioadhesion. Int. J. Pharm. 1984, 19 (2), 107–127.

   OpenUrl
4. 4.↵
   1. Chitnis V. S.,
   2. Malshe V. S.,
   3. Lalla J. K.

   Bioadhesive polymer synthesis, evaluation and application in controlled release tablets. Drug Dev. Ind. Pharm. 1991, 17 (6), 879–892.

   OpenUrl
5. 5.↵
   1. Kawashima Y.,
   2. Niwa T.,
   3. Takeuchi H.,
   4. Hino T.,
   5. Itoh Y.

   Hollow microspheres for use as a floating controlled drug delivery system in the stomach. J. Pharm. Sci. 1992, 81 (2), 135–140.

   OpenUrlPubMed
6. 6.↵
   1. Clarke G. M.,
   2. Newton J. M.,
   3. Short M. D.

   Gastrointestinal transit of pellets of differing size and density. Int. J. Pharm. 1993, 100 (1–3), 81–92.

   OpenUrl
7. 7.↵
   1. Klausner E. A.,
   2. Lavy E.,
   3. Friedman M.,
   4. Hoffman A.

   Expandable gastroretentive dosage forms. J. Controlled Release 2003, 90 (2), 143–162.

   OpenUrlPubMed
8. 8.↵
   1. Chen J.,
   2. Blevins W.E.,
   3. Park H.,
   4. Park K.

   Gastric retention properties of superporous hydrogel composites. J. Controlled Release 2000, 64 (1–3), 39–51.

   OpenUrlCrossRefPubMed
9. 9.↵
   1. Chen J.,
   2. Park K.

   Synthesis and characterization of superporous hydrogel composites. J. Controlled Release 2000, 65 (1–2), 73–82.

   OpenUrlPubMed
10. 10.↵
    1. Ito R.,
    2. Machida Y.,
    3. Sannan T.,
    4. Nagai T.

    Magnetic granules: a novel system for specific drug delivery to esophageal mucosa in oral administration. Int. J. Pharm. 1990, 61 (1–2), 109–117.

    OpenUrlCrossRefWeb of Science
11. 11.↵
    1. Bomma R.,
    2. Swamy Naidu R.A.,
    3. Yamsani M. R.,
    4. Veerabrahma K.

    Development and evaluation of gastroretentive norfloxacin floating tablets. Acta Pharm. 2009, 59 (2), 211–221.

    OpenUrlPubMed
12. 12.↵
    1. Flore K

    1. Mazuel C.

    Norfloxacin. In Analytical Profiles of Drug Substances, Flore K Ed.; Academic Press: San Diego, CA, 1991; Vol. 20, pp 557–600.

    OpenUrl
13. 13.↵
    1. Jaimini M.,
    2. Rana A.C.,
    3. Tanwar S.

    Formulation and evaluation of famotidine floating tablets. Current Drug Delivery 2007, 4 (1), 51–55.

    OpenUrlPubMed
14. 14.↵
    1. Jimenez-Castellanos M. R.,
    2. Zia H.,
    3. Rhodes C. T.

    Design and testing in vitro of a bioadhesive and floating drug delivery system for oral application. Int. J. Pharm. 1994, 105 (1), 65–70.

    OpenUrl
15. 15.↵
    1. Xu X.,
    2. Sun M.,
    3. Zhi F.,
    4. Hu Y.

    Floating matrix dosage form for phenoporlamine hydrochloride based on gas forming agent: in vitro and in vivo evaluation in healthy volunteers. Int. J. Pharm. 2006, 310 (1–2), 139–145.

    OpenUrlPubMed
16. 16.↵
    1. Hwang S. J.,
    2. Park H.,
    3. Park K.

    Gastric retentive drug-delivery systems. Crit. Rev. Ther. Drug Carrier Syst. 1998, 15 (3), 243–284.

    OpenUrlPubMedWeb of Science